Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for interscalene block after shoulder arthroscopy
ChiCTR2600119745Phase 4Not yet recruiting
- Sponsor
- Fuyang City Cancer Hospital
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in Rotator cuff deficiency (RCD) and postoperative pain comparing Group R (ropivacaine) with Group DR (liposomal bupivacaine) (2 arms). Primary endpoint: Resting pain NRS scores at multiple time points. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
Rotator cuff deficiency (RCD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2600119745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119745.